VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,641,703 | -13.2% | 2,104,835 | -2.8% | 0.65% | -9.7% |
| Q2 2023 | $65,232,832 | -9.0% | 2,166,485 | -2.2% | 0.72% | -11.4% |
| Q1 2023 | $71,654,038 | +10.8% | 2,214,964 | -1.8% | 0.81% | +9.5% |
| Q4 2022 | $64,644,607 | +3261.7% | 2,255,570 | +2722.5% | 0.74% | +2970.8% |
| Q3 2022 | $1,923,000 | -22.6% | 79,915 | -12.2% | 0.02% | -17.2% |
| Q2 2022 | $2,485,000 | -28.2% | 91,042 | +0.9% | 0.03% | -21.6% |
| Q1 2022 | $3,463,000 | +31.7% | 90,186 | +9.8% | 0.04% | +42.3% |
| Q4 2021 | $2,630,000 | +130.3% | 82,167 | +112.3% | 0.03% | +116.7% |
| Q3 2021 | $1,142,000 | -16.8% | 38,711 | -4.1% | 0.01% | -14.3% |
| Q2 2021 | $1,372,000 | +4.2% | 40,378 | -0.4% | 0.01% | -6.7% |
| Q1 2021 | $1,317,000 | -5.7% | 40,529 | +4.5% | 0.02% | -6.2% |
| Q4 2020 | $1,396,000 | -18.0% | 38,771 | -10.9% | 0.02% | -30.4% |
| Q3 2020 | $1,702,000 | -98.2% | 43,509 | -98.3% | 0.02% | -98.4% |
| Q2 2020 | $96,716,000 | -5.6% | 2,636,853 | -40.7% | 1.40% | -2.0% |
| Q1 2020 | $102,487,000 | +46.7% | 4,449,117 | +86.5% | 1.43% | +50.2% |
| Q4 2019 | $69,849,000 | +25025.5% | 2,385,514 | +22952.9% | 0.95% | +23700.0% |
| Q3 2019 | $278,000 | -7.9% | 10,348 | -12.4% | 0.00% | -20.0% |
| Q2 2019 | $302,000 | -11.2% | 11,812 | -22.4% | 0.01% | -16.7% |
| Q1 2019 | $340,000 | -77.7% | 15,212 | -79.0% | 0.01% | -78.6% |
| Q4 2018 | $1,526,000 | +4.6% | 72,292 | -8.3% | 0.03% | +21.7% |
| Q3 2018 | $1,459,000 | -23.7% | 78,813 | -8.0% | 0.02% | -28.1% |
| Q2 2018 | $1,912,000 | -2.5% | 85,634 | -3.9% | 0.03% | -3.0% |
| Q1 2018 | $1,961,000 | -17.2% | 89,127 | -12.6% | 0.03% | -19.5% |
| Q4 2017 | $2,369,000 | -90.2% | 101,968 | -90.3% | 0.04% | -91.1% |
| Q3 2017 | $24,255,000 | +3.2% | 1,056,451 | -0.7% | 0.46% | -2.1% |
| Q2 2017 | $23,492,000 | -11.6% | 1,063,851 | -8.6% | 0.47% | -15.3% |
| Q1 2017 | $26,561,000 | +5.8% | 1,164,383 | -3.0% | 0.56% | -2.5% |
| Q4 2016 | $25,099,000 | +1490.6% | 1,199,888 | +1909.7% | 0.57% | +1440.5% |
| Q3 2016 | $1,578,000 | +26.3% | 59,705 | +32.8% | 0.04% | +27.6% |
| Q2 2016 | $1,249,000 | – | 44,944 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |